由脂肪组织衍生的外体体封装的MiRNA-132/212会恶化动脉样硬化进展

Bei Guo1,2, Tong-Tian Zhuang3, Chang-Chun Li1

  • 1National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, 410000, China.

Cardiovascular diabetology
|September 9, 2024
PubMed
概括

脂肪组织外基因组通过促进细胞死亡和血管生长来加剧动脉样硬化. 这些外体内的微RNA-132/212驱动了这一过程,为治疗提供了潜在的点.